Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: Protection by diosgenin and l-deprenyl

Jadwiga Turchan-Cholewo, Yiling Liu, Suzanne Gartner, Rollie Reid, Chunfa Jie, Xuejun Peng, Kuey Chu C Chen, Ashok Chauhan, Norman Haughey, Roy Cutler, Mark P. Mattson, Carlos A Pardo-Villamizar, Katherine Conant, Ned Sacktor, Justin Charles McArthur, Kurt F. Hauser, Chandra Gairola, Avindra Nath

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus (HIV) infection continues to rise in drug-abusing populations and causes a dementing illness in a subset of individuals. Factors contributing to the development of dementia in this population remain unknown. We found that HIV-infected individuals with the E4 allele of Apolipoprotein E (ApoE) or history of intravenous drug abuse had increased oxidative stress in the CNS. In vitro studies showed that HIV proteins, gp120 and Tat, Tat + morphine but not tumor necrosis factor-α (TNF-α), caused increased neurotoxicity in human neuronal cultures with ApoE4 allele. Microarray analysis showed a differential alteration of transcripts involved in energy metabolism in cultures of ApoE3 and 4 neurons upon treatment with Tat + morphine. This was confirmed using assays of mitochondrial function and exposure of the neurons to Tat + morphine. Using this in vitro model, we screened a number of novel antioxidants and found that only l-deprenyl and diosgenin protected against the neurotoxicity of Tat + morphine. Furthermore, Tat-induced oxidative stress impaired morphine metabolism which could also be prevented by diosgenin. In conclusion, opiate abusers with HIV infection and the ApoE4 allele may be at increased risk of developing dementia. l-deprenyl and a plant estrogen, diosgenin, may have therapeutic potential in this population.

Original languageEnglish (US)
Pages (from-to)109-119
Number of pages11
JournalNeurobiology of Disease
Volume23
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Opiate Alkaloids
Diosgenin
Apolipoprotein E4
Human Immunodeficiency Virus Proteins
Selegiline
Morphine
Neurons
Alleles
HIV
Virus Diseases
Dementia
Oxidative Stress
Intravenous Substance Abuse
Apolipoprotein E3
Population
Phytoestrogens
Apolipoproteins E
Microarray Analysis
Energy Metabolism
Tumor Necrosis Factor-alpha

Keywords

  • ApoE4
  • Drug abuse
  • Genetics
  • HIV
  • Neuroprotection
  • Opiates
  • Oxidative stress
  • Tat

ASJC Scopus subject areas

  • Neurology

Cite this

Increased vulnerability of ApoE4 neurons to HIV proteins and opiates : Protection by diosgenin and l-deprenyl. / Turchan-Cholewo, Jadwiga; Liu, Yiling; Gartner, Suzanne; Reid, Rollie; Jie, Chunfa; Peng, Xuejun; Chen, Kuey Chu C; Chauhan, Ashok; Haughey, Norman; Cutler, Roy; Mattson, Mark P.; Pardo-Villamizar, Carlos A; Conant, Katherine; Sacktor, Ned; McArthur, Justin Charles; Hauser, Kurt F.; Gairola, Chandra; Nath, Avindra.

In: Neurobiology of Disease, Vol. 23, No. 1, 07.2006, p. 109-119.

Research output: Contribution to journalArticle

Turchan-Cholewo, J, Liu, Y, Gartner, S, Reid, R, Jie, C, Peng, X, Chen, KCC, Chauhan, A, Haughey, N, Cutler, R, Mattson, MP, Pardo-Villamizar, CA, Conant, K, Sacktor, N, McArthur, JC, Hauser, KF, Gairola, C & Nath, A 2006, 'Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: Protection by diosgenin and l-deprenyl', Neurobiology of Disease, vol. 23, no. 1, pp. 109-119. https://doi.org/10.1016/j.nbd.2006.02.005
Turchan-Cholewo, Jadwiga ; Liu, Yiling ; Gartner, Suzanne ; Reid, Rollie ; Jie, Chunfa ; Peng, Xuejun ; Chen, Kuey Chu C ; Chauhan, Ashok ; Haughey, Norman ; Cutler, Roy ; Mattson, Mark P. ; Pardo-Villamizar, Carlos A ; Conant, Katherine ; Sacktor, Ned ; McArthur, Justin Charles ; Hauser, Kurt F. ; Gairola, Chandra ; Nath, Avindra. / Increased vulnerability of ApoE4 neurons to HIV proteins and opiates : Protection by diosgenin and l-deprenyl. In: Neurobiology of Disease. 2006 ; Vol. 23, No. 1. pp. 109-119.
@article{deaf8473229c48868cf612c44d45e6eb,
title = "Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: Protection by diosgenin and l-deprenyl",
abstract = "Human immunodeficiency virus (HIV) infection continues to rise in drug-abusing populations and causes a dementing illness in a subset of individuals. Factors contributing to the development of dementia in this population remain unknown. We found that HIV-infected individuals with the E4 allele of Apolipoprotein E (ApoE) or history of intravenous drug abuse had increased oxidative stress in the CNS. In vitro studies showed that HIV proteins, gp120 and Tat, Tat + morphine but not tumor necrosis factor-α (TNF-α), caused increased neurotoxicity in human neuronal cultures with ApoE4 allele. Microarray analysis showed a differential alteration of transcripts involved in energy metabolism in cultures of ApoE3 and 4 neurons upon treatment with Tat + morphine. This was confirmed using assays of mitochondrial function and exposure of the neurons to Tat + morphine. Using this in vitro model, we screened a number of novel antioxidants and found that only l-deprenyl and diosgenin protected against the neurotoxicity of Tat + morphine. Furthermore, Tat-induced oxidative stress impaired morphine metabolism which could also be prevented by diosgenin. In conclusion, opiate abusers with HIV infection and the ApoE4 allele may be at increased risk of developing dementia. l-deprenyl and a plant estrogen, diosgenin, may have therapeutic potential in this population.",
keywords = "ApoE4, Drug abuse, Genetics, HIV, Neuroprotection, Opiates, Oxidative stress, Tat",
author = "Jadwiga Turchan-Cholewo and Yiling Liu and Suzanne Gartner and Rollie Reid and Chunfa Jie and Xuejun Peng and Chen, {Kuey Chu C} and Ashok Chauhan and Norman Haughey and Roy Cutler and Mattson, {Mark P.} and Pardo-Villamizar, {Carlos A} and Katherine Conant and Ned Sacktor and McArthur, {Justin Charles} and Hauser, {Kurt F.} and Chandra Gairola and Avindra Nath",
year = "2006",
month = "7",
doi = "10.1016/j.nbd.2006.02.005",
language = "English (US)",
volume = "23",
pages = "109--119",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Increased vulnerability of ApoE4 neurons to HIV proteins and opiates

T2 - Protection by diosgenin and l-deprenyl

AU - Turchan-Cholewo, Jadwiga

AU - Liu, Yiling

AU - Gartner, Suzanne

AU - Reid, Rollie

AU - Jie, Chunfa

AU - Peng, Xuejun

AU - Chen, Kuey Chu C

AU - Chauhan, Ashok

AU - Haughey, Norman

AU - Cutler, Roy

AU - Mattson, Mark P.

AU - Pardo-Villamizar, Carlos A

AU - Conant, Katherine

AU - Sacktor, Ned

AU - McArthur, Justin Charles

AU - Hauser, Kurt F.

AU - Gairola, Chandra

AU - Nath, Avindra

PY - 2006/7

Y1 - 2006/7

N2 - Human immunodeficiency virus (HIV) infection continues to rise in drug-abusing populations and causes a dementing illness in a subset of individuals. Factors contributing to the development of dementia in this population remain unknown. We found that HIV-infected individuals with the E4 allele of Apolipoprotein E (ApoE) or history of intravenous drug abuse had increased oxidative stress in the CNS. In vitro studies showed that HIV proteins, gp120 and Tat, Tat + morphine but not tumor necrosis factor-α (TNF-α), caused increased neurotoxicity in human neuronal cultures with ApoE4 allele. Microarray analysis showed a differential alteration of transcripts involved in energy metabolism in cultures of ApoE3 and 4 neurons upon treatment with Tat + morphine. This was confirmed using assays of mitochondrial function and exposure of the neurons to Tat + morphine. Using this in vitro model, we screened a number of novel antioxidants and found that only l-deprenyl and diosgenin protected against the neurotoxicity of Tat + morphine. Furthermore, Tat-induced oxidative stress impaired morphine metabolism which could also be prevented by diosgenin. In conclusion, opiate abusers with HIV infection and the ApoE4 allele may be at increased risk of developing dementia. l-deprenyl and a plant estrogen, diosgenin, may have therapeutic potential in this population.

AB - Human immunodeficiency virus (HIV) infection continues to rise in drug-abusing populations and causes a dementing illness in a subset of individuals. Factors contributing to the development of dementia in this population remain unknown. We found that HIV-infected individuals with the E4 allele of Apolipoprotein E (ApoE) or history of intravenous drug abuse had increased oxidative stress in the CNS. In vitro studies showed that HIV proteins, gp120 and Tat, Tat + morphine but not tumor necrosis factor-α (TNF-α), caused increased neurotoxicity in human neuronal cultures with ApoE4 allele. Microarray analysis showed a differential alteration of transcripts involved in energy metabolism in cultures of ApoE3 and 4 neurons upon treatment with Tat + morphine. This was confirmed using assays of mitochondrial function and exposure of the neurons to Tat + morphine. Using this in vitro model, we screened a number of novel antioxidants and found that only l-deprenyl and diosgenin protected against the neurotoxicity of Tat + morphine. Furthermore, Tat-induced oxidative stress impaired morphine metabolism which could also be prevented by diosgenin. In conclusion, opiate abusers with HIV infection and the ApoE4 allele may be at increased risk of developing dementia. l-deprenyl and a plant estrogen, diosgenin, may have therapeutic potential in this population.

KW - ApoE4

KW - Drug abuse

KW - Genetics

KW - HIV

KW - Neuroprotection

KW - Opiates

KW - Oxidative stress

KW - Tat

UR - http://www.scopus.com/inward/record.url?scp=33745248696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745248696&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2006.02.005

DO - 10.1016/j.nbd.2006.02.005

M3 - Article

C2 - 16697650

AN - SCOPUS:33745248696

VL - 23

SP - 109

EP - 119

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1

ER -